Ms Deanne Miller (General Counsel, Company Secretary, Chief Op. Officer) ...
BioNTech said that BNT327 has the "potential to replace current checkpoint inhibitor standard of care treatments for solid ...
Aethlon Medical reaches key milestone with enrollment of first patient in its Hemopurifier cancer trial in Australia: San Diego Wednesday, November 13, 2024, 15:30 Hrs [IST] Aethl ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback